Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

OT-551

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Nitroxide small molecule agents are in development as preventative or therapeutic pharmaceutical drugs for age-related macular… Expand
  • figure 1
  • table 1
Is this relevant?
Review
2013
Review
2013
Age-related macular degeneration (ARMD) is the leading cause of irreversible blindness in developed countries. There are… Expand
Is this relevant?
2010
2010
OT-551 (1-hydroxy-4-cyclopropanecarbonyloxy-2,2,6,6-tetramethylpiperidine hydrochloride), is a novel small molecule with… Expand
Is this relevant?
Review
2010
Review
2010
PURPOSE To investigate the safety and preliminary efficacy of OT-551, a disubstituted hydroxylamine with antioxidant properties… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE OT-551 (1-hydroxy-4-cyclopropanecarbonyloxy-2,2,6,6-tetramethylpiperidine hydrochloride), a TEMPOL-H (OT-674) derivative… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?